Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- Bristol-Myers Squibb Company (NYSE: BMY) hit a new 52-week high Monday as it is currently trading at $49.34, above its previous 52-week high of $48.83 with 11.3 million shares traded as of 11:20 a.m. ET. Average volume has been 10.7 million shares over the past 30 days. Bristol-Myers Squibb has a market cap of $77.23 billion and is part of the health care sector and drugs industry. Shares are up 41.2% year to date as of the close of trading on Friday. Bristol-Myers Squibb Company, a biopharmaceutical company, discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products that help patients prevail over serious diseases worldwide. The company has a P/E ratio of 52.8, above the S&P 500 P/E ratio of 17.7.